EKF Diagnostics Holdings plc
("EKF" or the "Company")
Result of AGM and Voting Results
EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed global diagnostics business, announces that at its Annual General Meeting ("AGM") held earlier today, all resolutions were duly passed.
The voting results of the AGM were as follows:
|
For |
Against |
Withheld |
||
Resolution |
Votes |
% |
Votes |
% |
Votes |
1 |
248,228,094 |
99.78% |
547,604 |
0.22% |
58,727,253 |
2 |
306,929,202 |
99.99% |
17,611 |
0.01% |
556,138 |
3 |
307,478,974 |
100.00% |
13,855 |
0.00% |
10,122 |
4 |
242,675,522 |
97.55% |
6,098,796 |
2.45% |
58,728,633 |
5 |
307,473,521 |
99.99% |
19,308 |
0.01% |
10,122 |
6 |
307,471,021 |
99.99% |
21,808 |
0.01% |
10,122 |
7 |
302,901,784 |
98.51% |
4,594,167 |
1.49% |
7,000 |
8 |
307,478,340 |
99.99% |
16,355 |
0.01% |
8,256 |
9 |
307,474,469 |
99.99% |
16,029 |
0.01% |
12,453 |
10* |
305,495,468 |
99.35% |
1,998,483 |
0.65% |
9,000 |
11* |
251,801,517 |
81.89% |
55,692,434 |
18.11% |
9,000 |
12* |
247,115,598 |
83.20% |
49,902,353 |
16.80% |
10,485,000 |
*Special Resolutions
EKF Diagnostics Holdings plc |
|||
Julian Baines, Executive Chair / Stephen Young, CFO |
via Walbrook PR |
||
|
|
||
Singer Capital Markets (Nominated Adviser & Broker) |
Tel: +44 (0)20 7496 3000 |
||
Aubrey Powell / Oliver Platts |
|
||
|
|
||
Walbrook PR Limited |
Tel: +44 (0)20 7933 8780 or ekf@walbrookpr.com |
||
Paul McManus / Alice Woodings |
Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654 |
||
About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)
EKF is an AIM-listed global diagnostics business focussed on:
● |
Point-of-Care analysers in the key areas of Hematology and Diabetes
|
● |
Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. |
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.